| Enzalutamide investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 77show all (up to 200) |
|---|
| → investigated in trials for | Malignant Prostate Neoplasmcancer 129 trials (43 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Prostate Neoplasm | 129 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Castration-Resistant Prostate Carcinomasubtype 88 trials (34 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Castration-Resistant Prostate Carcinoma | 88 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Neoplasmsubtype 35 trials (13 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Adenocarcinomasubtype 25 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Adenocarcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prostate Carcinoma 14 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Prostate Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasm 13 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 8 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 7 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neoplasmcancer_family 5 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 5 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Carcinoma 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hepatocellular Carcinomasubtype 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hepatocellular Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Small Cell Carcinoma 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Pancreatic Neoplasm 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Pancreatic Neoplasm | 3 | Observed | clinicaltrials | graph → |